Here’s What Supports Penumbra’s (PEN) Revenue Growth and Margin Expansion
Artisan Partners, an investment management company, released its first-quarter 2026 investor letter for the “Artisan Small Cap Fund”.
Posts Tagged ‘NYSE:PEN’
What Makes Penumbra (PEN) a Good Investment Choice?
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Small Cap Fund”.
Penumbra (PEN) Reported Revenue Growth of 16.9% in Q4
Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Health Care Fund”. A copy of the letter can be downloaded here.
Penumbra, Inc. (PEN): A Bull Case Theory
We came across a bullish thesis on Penumbra, Inc. on stocks subreddit by someroastedbeef. In this article, we will summarize the bulls’ thesis on PEN.
Penumbra (PEN) Climbs to All-Time High on $14.5-Billion Merger
We recently published 10 Stock With Eye-Popping Gains; 5 Are on Fresh Highs. Penumbra Inc. (NYSE:PEN) was one of the top performers on Thursday.
Penumbra, Inc. (NYSE:PEN) Q3 2025 Earnings Call Transcript
Penumbra, Inc. (NYSE:PEN) Q3 2025 Earnings Call Transcript November 5, 2025Penumbra, Inc. beats earnings expectations. Reported EPS is $0.97, expectations were $0.9.
Needham Upgrades Penumbra (PEN) to Buy Amid 2026 Growth Outlook
Penumbra, Inc. (NYSE:PEN) ranks among the best medical device stocks to invest in. Needham raised Penumbra, Inc.
12 Best Medical Device Stocks to Invest In Now
In this article, we will take a look at the 12 Best Medical Device Stocks to Invest In Now.
Penumbra, Inc. (PEN) Promotes Shruthi Narayan to President to Drive Global Growth
We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Penumbra, Inc. is one of them. Penumbra, Inc.
12 Best Healthcare Stocks to Buy and Hold for 5 Years
In this article, we will be taking a look at the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. The CEO and co-founder of Claimable, Dr.
What Makes Penumbra (PEN) a Good Investment?
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” second-quarter 2025 investor letter.
Penumbra, Inc. (PEN): A Bull Case Theory
We came across a bullish thesis on Penumbra, Inc. on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on PENz.
Should You Invest in Penumbra (PEN)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Penumbra, Inc. (NYSE:PEN) Q2 2025 Earnings Call Transcript
Penumbra, Inc. (NYSE:PEN) Q2 2025 Earnings Call Transcript July 29, 2025Penumbra, Inc. beats earnings expectations. Reported EPS is $0.86, expectations were $0.81.
Penumbra (PEN) Announces Completion of Enrollment in STORM-PE Clinical Trial
Penumbra, Inc. (NYSE:PEN) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.
11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds
In this article, we will discuss the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.
Should You Consider Adding Penumbra (PEN) To Your Portfolio?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Penumbra, Inc. (NYSE:PEN) Q1 2025 Earnings Call Transcript
Penumbra, Inc. (NYSE:PEN) Q1 2025 Earnings Call Transcript April 23, 2025Penumbra, Inc. beats earnings expectations. Reported EPS is $0.83, expectations were $0.66.
Penumbra, Inc. (NYSE:PEN) Q4 2024 Earnings Call Transcript
Penumbra, Inc. (NYSE:PEN) Q4 2024 Earnings Call Transcript February 18, 2025Penumbra, Inc. beats earnings expectations. Reported EPS is $0.97, expectations were $0.88.
Wells Fargo’s Best Growth Stocks: 28 Stocks With The Highest Consensus EPS Growth Estimates
In this piece, we will take a look at Wells Fargo's top growth stocks and the stocks with the highest consensus EPS growth estimates.
Penumbra, Inc. (PEN): A Bull Case Theory
We came across a bullish thesis on Penumbra, Inc. (PEN) on Twitter by northeasternsvf. In this article, we will summarize the bulls’ thesis on PEN. Penumbra, Inc.
Penumbra, Inc. (NYSE:PEN) Q3 2024 Earnings Call Transcript
Penumbra, Inc. (NYSE:PEN) Q3 2024 Earnings Call Transcript October 30, 2024Penumbra, Inc. beats earnings expectations. Reported EPS is $0.85, expectations were $0.69.
Penumbra, Inc. (NYSE:PEN) Q2 2024 Earnings Call Transcript
Penumbra, Inc. (NYSE:PEN) Q2 2024 Earnings Call Transcript July 30, 2024Penumbra, Inc. misses on earnings expectations. Reported EPS is $-1.55181 EPS, expectations were $0.56.
Penumbra, Inc. (NYSE:PEN) Q1 2024 Earnings Call Transcript
Penumbra, Inc. (NYSE:PEN) Q1 2024 Earnings Call Transcript May 7, 2024 Penumbra, Inc. misses on earnings expectations. Reported EPS is $0.2793 EPS, expectations were $0.42.
Penumbra, Inc. (NYSE:PEN) Q4 2023 Earnings Call Transcript
Penumbra, Inc. (NYSE:PEN) Q4 2023 Earnings Call Transcript February 22, 2024 Penumbra, Inc. beats earnings expectations. Reported EPS is $0.76, expectations were $0.71.
25 Most Valuable Medical Device Companies in the US
In this article, we will be taking a look at the 25 most valuable medical device companies in the US.
Is Penumbra (PEN) a Good Short Position?
Diamond Hill Capital, an investment management company, released its “Long-Short Fund” third-quarter 2023 investor letter. A copy of the same can be downloaded here.
Penumbra, Inc. (NYSE:PEN) Q3 2023 Earnings Call Transcript
Penumbra, Inc. (NYSE:PEN) Q3 2023 Earnings Call Transcript November 2, 2023 Penumbra, Inc. beats earnings expectations. Reported EPS is $0.67, expectations were $0.46.
Penumbra (PEN) Declined on Weak Second Quarter Earnings
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third quarter 2023 investor letter.
Artisan Partners Small Cap Fund Trimmed Penumbra (PEN) Based on Valuation Discipline
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.
Penumbra, Inc. (NYSE:PEN) Q2 2023 Earnings Call Transcript
Penumbra, Inc. (NYSE:PEN) Q2 2023 Earnings Call Transcript August 1, 2023 Penumbra, Inc. misses on earnings expectations. Reported EPS is $0.01 EPS, expectations were $0.28.
14 Best Multibagger Stocks to Buy for 2024
In this article, we discuss the 14 best multibagger stocks. Global Economic Outlook The last three years have been grueling for the bull market and the global economy.
Should You Invest in Penumbra (PEN)?
ClearBridge Investments, an investment management company, released its “ClearBridge SMID Cap Growth Strategy” first quarter 2023 investor letter.
Penumbra, Inc. (NYSE:PEN) Q1 2023 Earnings Call Transcript
Penumbra, Inc. (NYSE:PEN) Q1 2023 Earnings Call Transcript May 2, 2023 Operator: Good afternoon. My name is Julianne, and I will be your conference operator today.
Penumbra, Inc. (NYSE:PEN) Q4 2022 Earnings Call Transcript
Penumbra, Inc. (NYSE:PEN) Q4 2022 Earnings Call Transcript February 23, 2023 Operator: Good afternoon. My name is Kathy, and I will be your conference operator today.
12 Stocks To Sell According to Motley Fool
In this article, we will be looking at 12 stocks to sell according to Motley Fool.
15 Biggest Medical Device Companies in the World
In this article, we will take a look at the 15 biggest medical device companies in the world.
12 Best Medical Device Stocks To Buy Now
In this piece, we will take a look at the twelve best medical device stocks to buy now.
Is it Worthy to Own Penumbra (PEN) Shares?
ClearBridge Investments, an investment management firm, published its “SMID Cap Growth Strategy” fourth quarter 2021 investor letter – a copy of which can be downloaded ...
10 Stocks in Focus After Posting Their Earnings Reports
In this article, we will take a look at the 10 stocks in focus after posting their earnings reports.
Were Hedge Funds Right About Dumping Penumbra Inc (PEN)?
Does Penumbra Inc (NYSE:PEN) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund interest towards the company.
Is Redmile Group Right to Bet on Array Biopharma Inc (ARRY), Amicus Therapeutics, Inc. (FOLD) & Two Other Stocks?
Despite of all the negative sentiment looming around them, hedge funds had a pretty solid run for much of this year, generating positive returns for seven or eight consecutive...
Redmile Group Sticking With Healthcare Picks After Rough Q1
Redmile Group is a San Francisco-based, healthcare-focused hedge fund founded and managed by Jeremy Green, an Oxford alum with more than 20 years of experience in wealth management...
Does Penumbra Inc (PEN) Represent a Stock Worth Your Portfolio?
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the government.
Hedge Fund Resource Center
